Motif ID: Ebf3
Z-value: 1.200

Transcription factors associated with Ebf3:
Gene Symbol | Entrez ID | Gene Name |
---|---|---|
Ebf3 | ENSMUSG00000010476.7 | Ebf3 |
Activity-expression correlation:
Gene Symbol | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
Ebf3 | mm10_v2_chr7_-_137314394_137314445 | -0.50 | 8.6e-04 | Click! |
Top targets:
Gene overrepresentation in biological_process category:
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.5 | 7.6 | GO:0099548 | drug catabolic process(GO:0042737) exogenous drug catabolic process(GO:0042738) retrograde trans-synaptic signaling by soluble gas(GO:0098923) trans-synaptic signaling by nitric oxide(GO:0099548) |
2.3 | 6.8 | GO:0030827 | negative regulation of cGMP metabolic process(GO:0030824) negative regulation of cGMP biosynthetic process(GO:0030827) negative regulation of guanylate cyclase activity(GO:0031283) |
1.3 | 13.2 | GO:1902474 | positive regulation of protein localization to synapse(GO:1902474) |
0.8 | 2.4 | GO:1904139 | microglial cell migration(GO:1904124) regulation of microglial cell migration(GO:1904139) |
0.8 | 4.8 | GO:0097473 | cellular response to light intensity(GO:0071484) cellular response to high light intensity(GO:0071486) retinal rod cell apoptotic process(GO:0097473) |
0.7 | 10.6 | GO:0021902 | commitment of neuronal cell to specific neuron type in forebrain(GO:0021902) |
0.6 | 2.9 | GO:0090273 | regulation of somatostatin secretion(GO:0090273) |
0.6 | 1.7 | GO:1902460 | transforming growth factor beta activation(GO:0036363) regulation of mesenchymal stem cell proliferation(GO:1902460) positive regulation of mesenchymal stem cell proliferation(GO:1902462) |
0.6 | 2.2 | GO:0021564 | glossopharyngeal nerve development(GO:0021563) vagus nerve development(GO:0021564) |
0.5 | 1.1 | GO:2000974 | negative regulation of pro-B cell differentiation(GO:2000974) |
0.5 | 1.6 | GO:2000297 | negative regulation of synapse maturation(GO:2000297) |
0.5 | 2.8 | GO:0000160 | phosphorelay signal transduction system(GO:0000160) |
0.4 | 5.1 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
0.4 | 1.6 | GO:1904425 | negative regulation of GTP binding(GO:1904425) |
0.4 | 2.2 | GO:2000672 | negative regulation of motor neuron apoptotic process(GO:2000672) |
0.4 | 1.8 | GO:1900748 | positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
0.4 | 2.2 | GO:0097646 | calcitonin family receptor signaling pathway(GO:0097646) amylin receptor signaling pathway(GO:0097647) |
0.4 | 0.7 | GO:0048294 | negative regulation of isotype switching to IgE isotypes(GO:0048294) |
0.3 | 2.4 | GO:1990573 | potassium ion import across plasma membrane(GO:1990573) |
0.3 | 1.0 | GO:1904395 | positive regulation of skeletal muscle acetylcholine-gated channel clustering(GO:1904395) |
0.3 | 1.3 | GO:1904529 | regulation of actin filament binding(GO:1904529) regulation of actin binding(GO:1904616) |
0.3 | 1.2 | GO:0007352 | zygotic specification of dorsal/ventral axis(GO:0007352) |
0.3 | 1.5 | GO:1902309 | negative regulation of peptidyl-serine dephosphorylation(GO:1902309) |
0.3 | 0.8 | GO:0003219 | cardiac right ventricle formation(GO:0003219) |
0.3 | 2.5 | GO:0050908 | detection of light stimulus involved in visual perception(GO:0050908) detection of light stimulus involved in sensory perception(GO:0050962) |
0.3 | 1.9 | GO:0033031 | positive regulation of neutrophil apoptotic process(GO:0033031) |
0.3 | 1.1 | GO:0032914 | positive regulation of transforming growth factor beta1 production(GO:0032914) |
0.3 | 0.8 | GO:0019085 | early viral transcription(GO:0019085) |
0.3 | 2.1 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
0.3 | 0.8 | GO:0038003 | opioid receptor signaling pathway(GO:0038003) regulation of opioid receptor signaling pathway(GO:2000474) |
0.2 | 0.7 | GO:1900041 | intestinal D-glucose absorption(GO:0001951) negative regulation of interleukin-2 secretion(GO:1900041) terminal web assembly(GO:1902896) |
0.2 | 0.9 | GO:0042822 | pyridoxal phosphate metabolic process(GO:0042822) |
0.2 | 0.6 | GO:0016095 | polyprenol catabolic process(GO:0016095) |
0.2 | 1.0 | GO:2000551 | regulation of T-helper 2 cell cytokine production(GO:2000551) positive regulation of T-helper 2 cell cytokine production(GO:2000553) |
0.2 | 1.2 | GO:0072318 | clathrin coat disassembly(GO:0072318) |
0.2 | 1.0 | GO:0015692 | vanadium ion transport(GO:0015676) lead ion transport(GO:0015692) |
0.2 | 1.5 | GO:0070447 | positive regulation of oligodendrocyte progenitor proliferation(GO:0070447) |
0.2 | 3.3 | GO:0007252 | I-kappaB phosphorylation(GO:0007252) |
0.2 | 3.1 | GO:0035020 | regulation of Rac protein signal transduction(GO:0035020) |
0.2 | 1.4 | GO:0031339 | negative regulation of vesicle fusion(GO:0031339) |
0.2 | 0.9 | GO:0006344 | maintenance of chromatin silencing(GO:0006344) |
0.2 | 0.8 | GO:0035616 | histone H2B conserved C-terminal lysine deubiquitination(GO:0035616) |
0.1 | 1.6 | GO:0033327 | Leydig cell differentiation(GO:0033327) |
0.1 | 10.3 | GO:0038083 | peptidyl-tyrosine autophosphorylation(GO:0038083) |
0.1 | 0.9 | GO:0016557 | peroxisome membrane biogenesis(GO:0016557) regulation of peroxisome size(GO:0044375) |
0.1 | 0.4 | GO:0060010 | Sertoli cell fate commitment(GO:0060010) |
0.1 | 0.4 | GO:2001187 | natural killer cell mediated cytotoxicity directed against tumor cell target(GO:0002420) natural killer cell mediated immune response to tumor cell(GO:0002423) regulation of natural killer cell mediated immune response to tumor cell(GO:0002855) regulation of natural killer cell mediated cytotoxicity directed against tumor cell target(GO:0002858) positive regulation of CD8-positive, alpha-beta T cell activation(GO:2001187) |
0.1 | 1.8 | GO:0001765 | membrane raft assembly(GO:0001765) |
0.1 | 0.8 | GO:1903300 | negative regulation of glucokinase activity(GO:0033132) negative regulation of hexokinase activity(GO:1903300) |
0.1 | 1.1 | GO:0031642 | negative regulation of myelination(GO:0031642) |
0.1 | 1.8 | GO:0051386 | regulation of neurotrophin TRK receptor signaling pathway(GO:0051386) |
0.1 | 1.9 | GO:0001553 | luteinization(GO:0001553) |
0.1 | 0.5 | GO:0070278 | extracellular matrix constituent secretion(GO:0070278) |
0.1 | 0.9 | GO:0019896 | axonal transport of mitochondrion(GO:0019896) |
0.1 | 0.5 | GO:1902775 | mitochondrial large ribosomal subunit assembly(GO:1902775) |
0.1 | 1.5 | GO:0035414 | negative regulation of catenin import into nucleus(GO:0035414) |
0.1 | 2.1 | GO:0051764 | actin crosslink formation(GO:0051764) |
0.1 | 0.5 | GO:0046684 | response to pyrethroid(GO:0046684) |
0.1 | 0.5 | GO:0072675 | osteoclast fusion(GO:0072675) |
0.1 | 0.9 | GO:2000786 | positive regulation of autophagosome assembly(GO:2000786) |
0.1 | 2.1 | GO:0001990 | regulation of systemic arterial blood pressure by hormone(GO:0001990) |
0.1 | 0.3 | GO:0015910 | peroxisomal long-chain fatty acid import(GO:0015910) |
0.1 | 0.5 | GO:0071787 | endoplasmic reticulum tubular network assembly(GO:0071787) |
0.1 | 0.4 | GO:0008655 | pyrimidine-containing compound salvage(GO:0008655) pyrimidine nucleoside salvage(GO:0043097) |
0.1 | 0.6 | GO:0002710 | negative regulation of T cell mediated immunity(GO:0002710) |
0.1 | 0.2 | GO:1904211 | membrane protein proteolysis involved in retrograde protein transport, ER to cytosol(GO:1904211) |
0.1 | 0.7 | GO:0098887 | neurotransmitter receptor transport, endosome to postsynaptic membrane(GO:0098887) |
0.1 | 0.2 | GO:0006642 | triglyceride mobilization(GO:0006642) oncostatin-M-mediated signaling pathway(GO:0038165) regulation of interleukin-6-mediated signaling pathway(GO:0070103) negative regulation of interleukin-6-mediated signaling pathway(GO:0070104) |
0.1 | 1.1 | GO:0016322 | neuron remodeling(GO:0016322) |
0.1 | 1.9 | GO:0010971 | positive regulation of G2/M transition of mitotic cell cycle(GO:0010971) |
0.1 | 0.2 | GO:1990839 | response to endothelin(GO:1990839) |
0.1 | 0.1 | GO:0021773 | striatal medium spiny neuron differentiation(GO:0021773) |
0.1 | 1.2 | GO:0021516 | dorsal spinal cord development(GO:0021516) |
0.1 | 0.5 | GO:0010571 | positive regulation of nuclear cell cycle DNA replication(GO:0010571) |
0.1 | 0.3 | GO:0070164 | negative regulation of adiponectin secretion(GO:0070164) |
0.1 | 0.9 | GO:0048172 | regulation of short-term neuronal synaptic plasticity(GO:0048172) |
0.0 | 0.9 | GO:0045793 | positive regulation of cell size(GO:0045793) |
0.0 | 0.2 | GO:0042373 | vitamin K metabolic process(GO:0042373) |
0.0 | 0.8 | GO:1904262 | negative regulation of TORC1 signaling(GO:1904262) |
0.0 | 1.6 | GO:0048791 | calcium ion-regulated exocytosis of neurotransmitter(GO:0048791) |
0.0 | 0.6 | GO:0060732 | positive regulation of inositol phosphate biosynthetic process(GO:0060732) |
0.0 | 1.1 | GO:0048148 | behavioral response to cocaine(GO:0048148) |
0.0 | 1.5 | GO:0007520 | myoblast fusion(GO:0007520) |
0.0 | 1.4 | GO:0033344 | cholesterol efflux(GO:0033344) |
0.0 | 0.5 | GO:0048681 | negative regulation of axon regeneration(GO:0048681) |
0.0 | 0.3 | GO:0051503 | adenine nucleotide transport(GO:0051503) |
0.0 | 5.4 | GO:0018107 | peptidyl-threonine phosphorylation(GO:0018107) |
0.0 | 0.3 | GO:0071732 | cellular response to nitric oxide(GO:0071732) |
0.0 | 0.8 | GO:0052646 | alditol phosphate metabolic process(GO:0052646) |
0.0 | 0.9 | GO:0000731 | DNA synthesis involved in DNA repair(GO:0000731) |
0.0 | 0.5 | GO:0097186 | amelogenesis(GO:0097186) |
0.0 | 0.9 | GO:0042246 | tissue regeneration(GO:0042246) |
0.0 | 2.6 | GO:0055013 | cardiac muscle cell development(GO:0055013) |
0.0 | 0.1 | GO:0038128 | ERBB2 signaling pathway(GO:0038128) |
0.0 | 0.3 | GO:0033689 | negative regulation of osteoblast proliferation(GO:0033689) |
0.0 | 0.1 | GO:0019062 | virion attachment to host cell(GO:0019062) adhesion of symbiont to host cell(GO:0044650) |
0.0 | 1.3 | GO:0006904 | vesicle docking involved in exocytosis(GO:0006904) |
0.0 | 0.6 | GO:0006044 | N-acetylglucosamine metabolic process(GO:0006044) |
0.0 | 0.7 | GO:0046827 | positive regulation of protein export from nucleus(GO:0046827) |
0.0 | 0.5 | GO:0035767 | endothelial cell chemotaxis(GO:0035767) |
0.0 | 0.9 | GO:0000186 | activation of MAPKK activity(GO:0000186) |
0.0 | 0.9 | GO:0051443 | positive regulation of ubiquitin-protein transferase activity(GO:0051443) |
0.0 | 0.3 | GO:0032703 | negative regulation of interleukin-2 production(GO:0032703) |
0.0 | 0.5 | GO:0032288 | myelin assembly(GO:0032288) |
0.0 | 0.3 | GO:0045792 | negative regulation of cell size(GO:0045792) |
0.0 | 0.8 | GO:0070979 | protein K11-linked ubiquitination(GO:0070979) |
0.0 | 0.3 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
0.0 | 0.2 | GO:0006621 | protein retention in ER lumen(GO:0006621) |
0.0 | 1.4 | GO:0007200 | phospholipase C-activating G-protein coupled receptor signaling pathway(GO:0007200) |
0.0 | 1.3 | GO:0007157 | heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0007157) |
0.0 | 0.4 | GO:0051382 | kinetochore assembly(GO:0051382) |
0.0 | 1.0 | GO:0048013 | ephrin receptor signaling pathway(GO:0048013) |
0.0 | 0.2 | GO:0006488 | dolichol-linked oligosaccharide biosynthetic process(GO:0006488) |
0.0 | 0.2 | GO:0019243 | methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione(GO:0019243) methylglyoxal catabolic process(GO:0051596) methylglyoxal catabolic process to lactate(GO:0061727) |
0.0 | 0.6 | GO:1901522 | positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus(GO:1901522) |
0.0 | 0.6 | GO:1902857 | positive regulation of nonmotile primary cilium assembly(GO:1902857) |
0.0 | 0.1 | GO:0010572 | positive regulation of platelet activation(GO:0010572) |
0.0 | 0.4 | GO:0071625 | vocalization behavior(GO:0071625) |
0.0 | 0.1 | GO:0097369 | sodium ion import(GO:0097369) sodium ion import across plasma membrane(GO:0098719) sodium ion import into cell(GO:1990118) |
0.0 | 0.7 | GO:0060292 | long term synaptic depression(GO:0060292) |
0.0 | 0.2 | GO:0016486 | peptide hormone processing(GO:0016486) |
0.0 | 0.3 | GO:0070207 | protein homotrimerization(GO:0070207) |
0.0 | 2.0 | GO:0007568 | aging(GO:0007568) |
0.0 | 0.5 | GO:0032212 | positive regulation of telomere maintenance via telomerase(GO:0032212) |
0.0 | 0.2 | GO:0032292 | myelination in peripheral nervous system(GO:0022011) peripheral nervous system axon ensheathment(GO:0032292) |
0.0 | 0.0 | GO:0017183 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) |
0.0 | 0.2 | GO:0097435 | fibril organization(GO:0097435) |
0.0 | 0.1 | GO:0071243 | cellular response to arsenic-containing substance(GO:0071243) |
0.0 | 0.1 | GO:0007398 | ectoderm development(GO:0007398) |
0.0 | 0.4 | GO:0030534 | adult behavior(GO:0030534) |
0.0 | 0.1 | GO:0006107 | oxaloacetate metabolic process(GO:0006107) |
0.0 | 0.9 | GO:2000045 | regulation of G1/S transition of mitotic cell cycle(GO:2000045) |
0.0 | 0.1 | GO:0007096 | regulation of exit from mitosis(GO:0007096) |
Gene overrepresentation in cellular_component category:
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.2 | 11.6 | GO:0045298 | tubulin complex(GO:0045298) |
0.7 | 2.2 | GO:0097058 | CRLF-CLCF1 complex(GO:0097058) |
0.7 | 2.2 | GO:1990682 | CSF1-CSF1R complex(GO:1990682) |
0.7 | 7.6 | GO:0042582 | primary lysosome(GO:0005766) azurophil granule(GO:0042582) |
0.6 | 1.8 | GO:0045160 | myosin I complex(GO:0045160) |
0.5 | 6.8 | GO:0044327 | dendritic spine head(GO:0044327) |
0.4 | 2.2 | GO:1903440 | calcitonin family receptor complex(GO:1903439) amylin receptor complex(GO:1903440) |
0.4 | 1.6 | GO:1990769 | proximal neuron projection(GO:1990769) |
0.4 | 5.1 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
0.3 | 4.2 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
0.3 | 0.9 | GO:0043625 | delta DNA polymerase complex(GO:0043625) |
0.3 | 4.8 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
0.3 | 0.8 | GO:0098592 | cytoplasmic side of apical plasma membrane(GO:0098592) |
0.2 | 1.7 | GO:0098576 | lumenal side of membrane(GO:0098576) |
0.2 | 0.9 | GO:0008537 | proteasome activator complex(GO:0008537) |
0.2 | 1.0 | GO:0070826 | paraferritin complex(GO:0070826) |
0.2 | 1.5 | GO:0097433 | dense body(GO:0097433) |
0.2 | 1.0 | GO:0045179 | apical cortex(GO:0045179) |
0.1 | 2.7 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.1 | 1.5 | GO:0016342 | catenin complex(GO:0016342) |
0.1 | 9.7 | GO:0000118 | histone deacetylase complex(GO:0000118) |
0.1 | 1.9 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
0.1 | 1.2 | GO:0097449 | astrocyte projection(GO:0097449) |
0.1 | 0.7 | GO:0016600 | flotillin complex(GO:0016600) |
0.1 | 1.5 | GO:0071564 | npBAF complex(GO:0071564) |
0.1 | 2.6 | GO:0032809 | neuronal cell body membrane(GO:0032809) |
0.1 | 11.9 | GO:0031234 | extrinsic component of cytoplasmic side of plasma membrane(GO:0031234) |
0.1 | 3.3 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
0.1 | 0.6 | GO:0000127 | transcription factor TFIIIC complex(GO:0000127) |
0.1 | 0.7 | GO:0098845 | postsynaptic endosome(GO:0098845) |
0.1 | 0.3 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
0.1 | 0.9 | GO:0070938 | contractile ring(GO:0070938) |
0.1 | 1.3 | GO:0000145 | exocyst(GO:0000145) |
0.1 | 2.8 | GO:0031941 | filamentous actin(GO:0031941) |
0.1 | 0.8 | GO:0061700 | GATOR2 complex(GO:0061700) |
0.1 | 0.4 | GO:0097513 | myosin II filament(GO:0097513) |
0.1 | 0.9 | GO:1904115 | axon cytoplasm(GO:1904115) |
0.1 | 3.6 | GO:0008076 | voltage-gated potassium channel complex(GO:0008076) |
0.0 | 0.7 | GO:0005869 | dynactin complex(GO:0005869) |
0.0 | 0.2 | GO:0070552 | BRISC complex(GO:0070552) |
0.0 | 0.5 | GO:0030056 | hemidesmosome(GO:0030056) |
0.0 | 0.6 | GO:0031105 | septin complex(GO:0031105) |
0.0 | 0.7 | GO:0097470 | ribbon synapse(GO:0097470) |
0.0 | 1.3 | GO:0019897 | extrinsic component of plasma membrane(GO:0019897) |
0.0 | 0.4 | GO:0042101 | T cell receptor complex(GO:0042101) |
0.0 | 1.1 | GO:0005779 | integral component of peroxisomal membrane(GO:0005779) |
0.0 | 0.8 | GO:0030285 | integral component of synaptic vesicle membrane(GO:0030285) intrinsic component of synaptic vesicle membrane(GO:0098563) |
0.0 | 0.5 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
0.0 | 0.3 | GO:0031931 | TORC1 complex(GO:0031931) |
0.0 | 0.9 | GO:0032281 | AMPA glutamate receptor complex(GO:0032281) |
0.0 | 0.5 | GO:0043218 | compact myelin(GO:0043218) |
0.0 | 1.4 | GO:0005871 | kinesin complex(GO:0005871) |
0.0 | 1.7 | GO:0001669 | acrosomal vesicle(GO:0001669) |
0.0 | 1.0 | GO:0030173 | integral component of Golgi membrane(GO:0030173) |
0.0 | 0.5 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
0.0 | 0.3 | GO:0005751 | mitochondrial respiratory chain complex IV(GO:0005751) |
0.0 | 0.5 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
0.0 | 1.1 | GO:0030864 | cortical actin cytoskeleton(GO:0030864) |
0.0 | 0.5 | GO:0005697 | telomerase holoenzyme complex(GO:0005697) |
0.0 | 1.3 | GO:0005913 | cell-cell adherens junction(GO:0005913) |
0.0 | 0.1 | GO:0000813 | ESCRT I complex(GO:0000813) |
0.0 | 0.5 | GO:0002102 | podosome(GO:0002102) |
0.0 | 0.2 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
0.0 | 0.9 | GO:0005776 | autophagosome(GO:0005776) |
0.0 | 0.3 | GO:0001917 | photoreceptor inner segment(GO:0001917) |
0.0 | 0.4 | GO:0000314 | organellar small ribosomal subunit(GO:0000314) mitochondrial small ribosomal subunit(GO:0005763) |
0.0 | 2.8 | GO:0014069 | postsynaptic density(GO:0014069) postsynaptic specialization(GO:0099572) |
Gene overrepresentation in molecular_function category:
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.5 | 7.6 | GO:0004517 | nitric-oxide synthase activity(GO:0004517) |
1.7 | 11.6 | GO:0099609 | microtubule lateral binding(GO:0099609) |
0.7 | 2.0 | GO:0008113 | peptide-methionine (S)-S-oxide reductase activity(GO:0008113) |
0.5 | 2.4 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
0.5 | 2.8 | GO:0000155 | phosphorelay sensor kinase activity(GO:0000155) |
0.5 | 5.1 | GO:0008603 | cAMP-dependent protein kinase regulator activity(GO:0008603) |
0.4 | 2.2 | GO:0097643 | amylin receptor activity(GO:0097643) |
0.4 | 1.6 | GO:0045131 | pre-mRNA branch point binding(GO:0045131) |
0.4 | 1.4 | GO:0034041 | sterol-transporting ATPase activity(GO:0034041) |
0.4 | 2.1 | GO:0005042 | netrin receptor activity(GO:0005042) |
0.4 | 2.5 | GO:0005127 | ciliary neurotrophic factor receptor binding(GO:0005127) |
0.3 | 0.9 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
0.3 | 11.8 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
0.3 | 2.6 | GO:0035374 | chondroitin sulfate binding(GO:0035374) |
0.3 | 1.2 | GO:0030348 | syntaxin-3 binding(GO:0030348) |
0.2 | 1.9 | GO:0046934 | phosphatidylinositol-4,5-bisphosphate 3-kinase activity(GO:0046934) phosphatidylinositol bisphosphate kinase activity(GO:0052813) |
0.2 | 3.3 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
0.2 | 1.1 | GO:0043812 | phosphatidylinositol-4-phosphate phosphatase activity(GO:0043812) |
0.2 | 0.9 | GO:0033883 | pyridoxal phosphatase activity(GO:0033883) |
0.2 | 0.6 | GO:0047751 | 3-oxo-5-alpha-steroid 4-dehydrogenase activity(GO:0003865) steroid dehydrogenase activity, acting on the CH-CH group of donors(GO:0033765) enone reductase activity(GO:0035671) cholestenone 5-alpha-reductase activity(GO:0047751) |
0.2 | 1.0 | GO:0015086 | cadmium ion transmembrane transporter activity(GO:0015086) lead ion transmembrane transporter activity(GO:0015094) vanadium ion transmembrane transporter activity(GO:0015100) ferrous iron uptake transmembrane transporter activity(GO:0015639) |
0.2 | 1.2 | GO:0070697 | activin receptor binding(GO:0070697) |
0.2 | 2.2 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.2 | 1.7 | GO:0031005 | filamin binding(GO:0031005) |
0.1 | 1.5 | GO:0008199 | ferric iron binding(GO:0008199) |
0.1 | 2.2 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
0.1 | 0.7 | GO:0001517 | N-acetylglucosamine 6-O-sulfotransferase activity(GO:0001517) |
0.1 | 5.6 | GO:0004683 | calmodulin-dependent protein kinase activity(GO:0004683) |
0.1 | 1.5 | GO:0050815 | phosphoserine binding(GO:0050815) |
0.1 | 1.7 | GO:0016641 | oxidoreductase activity, acting on the CH-NH2 group of donors, oxygen as acceptor(GO:0016641) |
0.1 | 0.3 | GO:0071936 | coreceptor activity involved in Wnt signaling pathway(GO:0071936) |
0.1 | 0.9 | GO:0061133 | endopeptidase activator activity(GO:0061133) |
0.1 | 1.1 | GO:0004806 | triglyceride lipase activity(GO:0004806) |
0.1 | 0.3 | GO:0046964 | 3'-phosphoadenosine 5'-phosphosulfate transmembrane transporter activity(GO:0046964) |
0.1 | 0.7 | GO:0032051 | clathrin light chain binding(GO:0032051) |
0.1 | 0.5 | GO:0038132 | neuregulin binding(GO:0038132) |
0.1 | 0.8 | GO:0003993 | acid phosphatase activity(GO:0003993) |
0.1 | 0.4 | GO:0004849 | uridine kinase activity(GO:0004849) |
0.1 | 0.5 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
0.1 | 0.2 | GO:0000033 | alpha-1,3-mannosyltransferase activity(GO:0000033) |
0.1 | 1.3 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
0.1 | 3.9 | GO:0030971 | receptor tyrosine kinase binding(GO:0030971) |
0.1 | 1.8 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
0.1 | 0.5 | GO:0086006 | voltage-gated sodium channel activity involved in cardiac muscle cell action potential(GO:0086006) |
0.1 | 0.7 | GO:0034236 | protein kinase A catalytic subunit binding(GO:0034236) |
0.1 | 1.8 | GO:0005158 | insulin receptor binding(GO:0005158) |
0.1 | 5.1 | GO:0005080 | protein kinase C binding(GO:0005080) |
0.1 | 1.3 | GO:0043274 | phospholipase binding(GO:0043274) |
0.1 | 0.6 | GO:0004886 | 9-cis retinoic acid receptor activity(GO:0004886) |
0.1 | 0.9 | GO:0050811 | GABA receptor binding(GO:0050811) |
0.1 | 0.3 | GO:0005324 | long-chain fatty acid transporter activity(GO:0005324) |
0.1 | 0.3 | GO:0047184 | 1-acylglycerophosphocholine O-acyltransferase activity(GO:0047184) |
0.0 | 0.2 | GO:0004090 | carbonyl reductase (NADPH) activity(GO:0004090) |
0.0 | 0.2 | GO:0046923 | ER retention sequence binding(GO:0046923) |
0.0 | 0.3 | GO:0003831 | beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity(GO:0003831) |
0.0 | 2.3 | GO:0070888 | E-box binding(GO:0070888) |
0.0 | 1.8 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
0.0 | 0.5 | GO:0003964 | telomerase activity(GO:0003720) RNA-directed DNA polymerase activity(GO:0003964) |
0.0 | 0.4 | GO:0035014 | retinoic acid binding(GO:0001972) phosphatidylinositol 3-kinase regulator activity(GO:0035014) |
0.0 | 1.6 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
0.0 | 0.7 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.0 | 1.6 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
0.0 | 0.5 | GO:0035497 | cAMP response element binding(GO:0035497) |
0.0 | 0.8 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
0.0 | 1.1 | GO:0048020 | CCR chemokine receptor binding(GO:0048020) |
0.0 | 0.8 | GO:0050431 | transforming growth factor beta binding(GO:0050431) |
0.0 | 0.7 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
0.0 | 0.9 | GO:0034061 | DNA-directed DNA polymerase activity(GO:0003887) DNA polymerase activity(GO:0034061) |
0.0 | 0.1 | GO:0030160 | GKAP/Homer scaffold activity(GO:0030160) |
0.0 | 0.2 | GO:0042500 | aspartic endopeptidase activity, intramembrane cleaving(GO:0042500) |
0.0 | 2.3 | GO:0005125 | cytokine activity(GO:0005125) |
0.0 | 0.1 | GO:0003996 | acyl-CoA ligase activity(GO:0003996) |
0.0 | 3.4 | GO:0016810 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds(GO:0016810) |
0.0 | 0.2 | GO:0004416 | hydroxyacylglutathione hydrolase activity(GO:0004416) |
0.0 | 0.7 | GO:0017046 | peptide hormone binding(GO:0017046) |
0.0 | 0.2 | GO:0001515 | opioid peptide activity(GO:0001515) |
0.0 | 0.3 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
0.0 | 1.0 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.0 | 0.1 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
0.0 | 1.5 | GO:0005249 | voltage-gated potassium channel activity(GO:0005249) |
0.0 | 0.4 | GO:0005528 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
0.0 | 0.7 | GO:0050699 | WW domain binding(GO:0050699) |
0.0 | 2.3 | GO:0030165 | PDZ domain binding(GO:0030165) |
0.0 | 2.2 | GO:0004725 | protein tyrosine phosphatase activity(GO:0004725) |
0.0 | 0.4 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
0.0 | 1.1 | GO:0008013 | beta-catenin binding(GO:0008013) |
0.0 | 0.3 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
0.0 | 0.1 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
0.0 | 0.7 | GO:0004712 | protein serine/threonine/tyrosine kinase activity(GO:0004712) |
0.0 | 8.9 | GO:0003682 | chromatin binding(GO:0003682) |
0.0 | 0.1 | GO:0015386 | potassium:proton antiporter activity(GO:0015386) |
0.0 | 5.5 | GO:0003779 | actin binding(GO:0003779) |
0.0 | 0.3 | GO:0004129 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
0.0 | 1.4 | GO:0044325 | ion channel binding(GO:0044325) |
0.0 | 0.2 | GO:0102391 | decanoate--CoA ligase activity(GO:0102391) |
0.0 | 0.9 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.0 | 0.7 | GO:0004721 | phosphoprotein phosphatase activity(GO:0004721) |
0.0 | 0.8 | GO:0004197 | cysteine-type endopeptidase activity(GO:0004197) |
Gene overrepresentation in C2:CP category:
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.6 | 11.6 | PID_P38_GAMMA_DELTA_PATHWAY | Signaling mediated by p38-gamma and p38-delta |
0.2 | 2.4 | SA_MMP_CYTOKINE_CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.2 | 6.9 | SA_TRKA_RECEPTOR | The TrkA receptor binds nerve growth factor to activate MAP kinase pathways and promote cell growth. |
0.1 | 5.4 | PID_RAS_PATHWAY | Regulation of Ras family activation |
0.1 | 3.3 | PID_NFKAPPAB_CANONICAL_PATHWAY | Canonical NF-kappaB pathway |
0.1 | 2.0 | PID_RET_PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.1 | 3.3 | PID_INTEGRIN_A4B1_PATHWAY | Alpha4 beta1 integrin signaling events |
0.1 | 2.4 | ST_G_ALPHA_I_PATHWAY | G alpha i Pathway |
0.1 | 2.1 | PID_NETRIN_PATHWAY | Netrin-mediated signaling events |
0.1 | 13.1 | PID_PDGFRB_PATHWAY | PDGFR-beta signaling pathway |
0.1 | 0.4 | ST_TYPE_I_INTERFERON_PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
0.1 | 0.7 | PID_SYNDECAN_2_PATHWAY | Syndecan-2-mediated signaling events |
0.0 | 0.3 | PID_INTEGRIN4_PATHWAY | Alpha6 beta4 integrin-ligand interactions |
0.0 | 1.1 | PID_A6B1_A6B4_INTEGRIN_PATHWAY | a6b1 and a6b4 Integrin signaling |
0.0 | 2.7 | PID_ERA_GENOMIC_PATHWAY | Validated nuclear estrogen receptor alpha network |
0.0 | 0.9 | PID_HIF2PATHWAY | HIF-2-alpha transcription factor network |
0.0 | 0.9 | ST_JNK_MAPK_PATHWAY | JNK MAPK Pathway |
0.0 | 1.2 | PID_BMP_PATHWAY | BMP receptor signaling |
0.0 | 1.4 | PID_LKB1_PATHWAY | LKB1 signaling events |
0.0 | 1.3 | PID_ARF6_TRAFFICKING_PATHWAY | Arf6 trafficking events |
0.0 | 0.6 | PID_MYC_PATHWAY | C-MYC pathway |
0.0 | 0.2 | PID_IL27_PATHWAY | IL27-mediated signaling events |
0.0 | 0.4 | PID_RXR_VDR_PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
0.0 | 0.7 | PID_CDC42_PATHWAY | CDC42 signaling events |
0.0 | 2.5 | NABA_ECM_REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.0 | 0.3 | PID_ARF6_DOWNSTREAM_PATHWAY | Arf6 downstream pathway |
0.0 | 0.3 | PID_NCADHERIN_PATHWAY | N-cadherin signaling events |
0.0 | 0.4 | PID_DELTA_NP63_PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
0.0 | 0.3 | PID_PI3KCI_AKT_PATHWAY | Class I PI3K signaling events mediated by Akt |
0.0 | 0.8 | PID_RB_1PATHWAY | Regulation of retinoblastoma protein |
0.0 | 2.2 | NABA_SECRETED_FACTORS | Genes encoding secreted soluble factors |
0.0 | 0.1 | ST_P38_MAPK_PATHWAY | p38 MAPK Pathway |
Gene overrepresentation in C2:CP:REACTOME category:
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.5 | 10.6 | REACTOME_CASPASE_MEDIATED_CLEAVAGE_OF_CYTOSKELETAL_PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
0.4 | 2.8 | REACTOME_SEMA3A_PLEXIN_REPULSION_SIGNALING_BY_INHIBITING_INTEGRIN_ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
0.4 | 7.7 | REACTOME_CRMPS_IN_SEMA3A_SIGNALING | Genes involved in CRMPs in Sema3A signaling |
0.3 | 4.8 | REACTOME_NEGATIVE_REGULATION_OF_THE_PI3K_AKT_NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
0.2 | 6.9 | REACTOME_LATENT_INFECTION_OF_HOMO_SAPIENS_WITH_MYCOBACTERIUM_TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
0.2 | 5.1 | REACTOME_PKA_MEDIATED_PHOSPHORYLATION_OF_CREB | Genes involved in PKA-mediated phosphorylation of CREB |
0.2 | 2.1 | REACTOME_ROLE_OF_DCC_IN_REGULATING_APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
0.1 | 5.4 | REACTOME_VOLTAGE_GATED_POTASSIUM_CHANNELS | Genes involved in Voltage gated Potassium channels |
0.1 | 0.6 | REACTOME_ANDROGEN_BIOSYNTHESIS | Genes involved in Androgen biosynthesis |
0.1 | 1.1 | REACTOME_SYNTHESIS_OF_PIPS_AT_THE_EARLY_ENDOSOME_MEMBRANE | Genes involved in Synthesis of PIPs at the early endosome membrane |
0.1 | 3.8 | REACTOME_HS_GAG_BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.1 | 2.7 | REACTOME_RAS_ACTIVATION_UOPN_CA2_INFUX_THROUGH_NMDA_RECEPTOR | Genes involved in Ras activation uopn Ca2+ infux through NMDA receptor |
0.1 | 0.9 | REACTOME_REMOVAL_OF_THE_FLAP_INTERMEDIATE_FROM_THE_C_STRAND | Genes involved in Removal of the Flap Intermediate from the C-strand |
0.1 | 2.9 | REACTOME_SYNTHESIS_OF_PIPS_AT_THE_PLASMA_MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
0.1 | 1.7 | REACTOME_ABCA_TRANSPORTERS_IN_LIPID_HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
0.1 | 2.4 | REACTOME_INHIBITION_OF_VOLTAGE_GATED_CA2_CHANNELS_VIA_GBETA_GAMMA_SUBUNITS | Genes involved in Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits |
0.1 | 1.6 | REACTOME_RAP1_SIGNALLING | Genes involved in Rap1 signalling |
0.1 | 1.3 | REACTOME_INSULIN_SYNTHESIS_AND_PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.1 | 1.5 | REACTOME_SIGNALING_BY_HIPPO | Genes involved in Signaling by Hippo |
0.1 | 1.9 | REACTOME_ION_TRANSPORT_BY_P_TYPE_ATPASES | Genes involved in Ion transport by P-type ATPases |
0.0 | 2.8 | REACTOME_CLASS_B_2_SECRETIN_FAMILY_RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.0 | 0.8 | REACTOME_CONVERSION_FROM_APC_C_CDC20_TO_APC_C_CDH1_IN_LATE_ANAPHASE | Genes involved in Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase |
0.0 | 1.1 | REACTOME_CHEMOKINE_RECEPTORS_BIND_CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.0 | 1.0 | REACTOME_TGF_BETA_RECEPTOR_SIGNALING_IN_EMT_EPITHELIAL_TO_MESENCHYMAL_TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.0 | 0.3 | REACTOME_ACYL_CHAIN_REMODELLING_OF_PS | Genes involved in Acyl chain remodelling of PS |
0.0 | 1.6 | REACTOME_REGULATION_OF_INSULIN_SECRETION | Genes involved in Regulation of Insulin Secretion |
0.0 | 1.2 | REACTOME_LYSOSOME_VESICLE_BIOGENESIS | Genes involved in Lysosome Vesicle Biogenesis |
0.0 | 0.8 | REACTOME_YAP1_AND_WWTR1_TAZ_STIMULATED_GENE_EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.0 | 0.6 | REACTOME_KERATAN_SULFATE_BIOSYNTHESIS | Genes involved in Keratan sulfate biosynthesis |
0.0 | 0.4 | REACTOME_REGULATION_OF_BETA_CELL_DEVELOPMENT | Genes involved in Regulation of beta-cell development |
0.0 | 0.6 | REACTOME_RNA_POL_III_TRANSCRIPTION_INITIATION_FROM_TYPE_2_PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 2 Promoter |
0.0 | 0.2 | REACTOME_IL_6_SIGNALING | Genes involved in Interleukin-6 signaling |
0.0 | 0.7 | REACTOME_RECYCLING_PATHWAY_OF_L1 | Genes involved in Recycling pathway of L1 |
0.0 | 0.3 | REACTOME_AKT_PHOSPHORYLATES_TARGETS_IN_THE_CYTOSOL | Genes involved in AKT phosphorylates targets in the cytosol |
0.0 | 0.4 | REACTOME_PYRIMIDINE_METABOLISM | Genes involved in Pyrimidine metabolism |
0.0 | 0.5 | REACTOME_SIGNALING_BY_BMP | Genes involved in Signaling by BMP |
0.0 | 0.3 | REACTOME_A_TETRASACCHARIDE_LINKER_SEQUENCE_IS_REQUIRED_FOR_GAG_SYNTHESIS | Genes involved in A tetrasaccharide linker sequence is required for GAG synthesis |
0.0 | 0.1 | REACTOME_MEMBRANE_BINDING_AND_TARGETTING_OF_GAG_PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
0.0 | 1.0 | REACTOME_NUCLEAR_RECEPTOR_TRANSCRIPTION_PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.0 | 0.5 | REACTOME_INTERACTION_BETWEEN_L1_AND_ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.0 | 0.2 | REACTOME_SHC1_EVENTS_IN_EGFR_SIGNALING | Genes involved in SHC1 events in EGFR signaling |
0.0 | 0.4 | REACTOME_SEMA4D_INDUCED_CELL_MIGRATION_AND_GROWTH_CONE_COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
0.0 | 0.8 | REACTOME_NRAGE_SIGNALS_DEATH_THROUGH_JNK | Genes involved in NRAGE signals death through JNK |